The generation of a robust and stable cell line is a fundamental step in any biopharmaceutical development project.
We offer mammalian cell line development with different high expression CHO cell lines and technology solutions, such as the production of monoclonal antibodies or other glycosylated non-mAb proteins. Through the application of genetic engineering and gene expression studies we find the clone with the best expression.
Since glycosylation pattern and product quality are affected by the choice of cell line and the cell culture process, Boehringer Ingelheim BioXcellence™ pays great attention to critical process parameters. We carefully monitor the cell line development. Feasibility studies identify the most suitable expression system for each product.
Find out more about Boehringer Ingelheim BioXcellence's™ High Expression Technology (BI-HEX®).